MARCAIN

This brand name is authorized in Hong Kong, Ireland, Japan, Lithuania, Malta, New Zealand, United Kingdom

Active ingredients

The drug MARCAIN contains one active pharmaceutical ingredient (API):

1 Bupivacaine UNII 7TQO7W3VT8 - BUPIVACAINE HYDROCHLORIDE

Bupivacaine is an amide-type, long-acting local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation. Read about Bupivacaine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MARCAIN POLYAMP STERIPACK Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
MARCAIN HEAVY Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N01BB01	Bupivacaine	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 209408, 209410, 44753
Country: HK	Department of Health Drug Office	Identifier(s): 35572, 35573, 42437
Country: JP	医薬品医療機器総合機構	Identifier(s): 1214403A1026, 1214403A2022, 1214403A3029, 1214403A4025, 1214403A5021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1087821, 1088348, 1090655
Country: MT	Medicines Authority	Identifier(s): MA955/01101
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1101, 1108, 1110, 1113